Is IMNN or IMRX more undervalued in 2026?

CirclFi compares Imunon, Inc. (IMNN) and Immuneering Corporation (IMRX) using 13 institutional-grade valuation models. IMNN has a Quality of Company score of 4.4/10 while IMRX scores 4.5/10.

Which is a better buy — IMNN or IMRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IMNN and IMRX valuations compare?

IMNN at $2.18 and IMRX at $5.77 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IMNN vs IMRX Valuation Comparison 2026 — Intrinsic Value Analysis

IMNN

Pharmaceutical Preparations

Imunon, Inc.

Quality

4.4

out of 10

Value Trap

LOW

Price

$2.18

Last close

Models

7/13

Active

IMRX

Pharmaceutical Preparations

Immuneering Corporation

Quality

4.5

out of 10

Value Trap

LOW

Price

$5.77

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	IMNN Fair Value	IMNN Upside	IMRX Fair Value	IMRX Upside
Bayesian DCF	Intrinsic	$1.10	-49.7%	$1.71	-70.4%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.10	-96.3%	$1.67	-71.1%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IMNN vs IMRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IMNN vs IMRX — Which Stock Is More Undervalued?

IMRX scores higher with a 4.5/10 quality rating vs IMNN's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Imunon, Inc. (IMNN) and Immuneering Corporation (IMRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IMNN currently trades at $2.18 with a QOC of 4.4/10, while IMRX trades at $5.77 with a QOC of 4.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).